Belvedere Trading LLC Merrimack Pharmaceuticals Inc Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$11.35 - $12.32 $318,957 - $346,216
-28,102 Reduced 72.07%
10,888 $133,000
Q4 2022

Feb 14, 2023
BUY
$3.68 - $12.51 $69,691 - $236,914
18,938 Added 94.44%
38,990 $446,000
Q3 2022

Oct 26, 2022
BUY
$3.7 - $6.06 $74,192 - $121,515
20,052 New
20,052 $77,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email